| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |